secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2023-08-03T23:59:59+00:00
Accession:  0001562762-23-000305
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical Q2 net sales $292M (+10.6% YoY); raises FY 2023 guidance to $1.125B
--------------------------------------------------------------------------------

- Net sales $291.6M, up 10.6% YoY; GAAP net income $57.7M (+5.7%).
- GAAP diluted EPS $0.57; non-GAAP diluted EPS $0.63 (+12.3%).
- Non-GAAP adjusted EBITDA $96.1M (33.0% of sales).
- Raised FY 2023 net sales guidance to $1.125B (from $1.100B); reaffirmed non-GAAP EPS $2.30.
- Launched REFLECT Scoliosis Correction System and MARVEL Growing Rod System.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000156276223000305/0001562762-23-000305-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000156276223000305/gmed-20230803x8k.htm
  HTML page:      https://secwatch.observer/filing/0001562762-23-000305

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer